Viking Global Investors
PMVP icon

Viking Global Investors’s PMV Pharmaceuticals PMVP Stock Holding History

Viking Global Investors’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,076,000
Closed -$22.4M – 95
2022
Q1 		$22.4M Sell
1,076,000
-714,284
-40% -$12.6M 0.09% 84
2021
Q4 		$41.4M Hold
1,790,284
– – 0.12% 90
2021
Q3 		$53.4M Hold
1,790,284
– – 0.15% 82
2021
Q2 		$61.2M Sell
1,790,284
-296,000
-14% -$9.89M 0.19% 72
2021
Q1 		$68.6M Sell
2,086,284
-277,778
-12% -$10.9M 0.2% 77
2020
Q4 		$145M Sell
2,364,062
-277,778
-11% -$10.9M 0.4% 61
2020
Q3 		$93.8M Buy
+2,641,840
New +$97.2M 0.34% 63

Other funds holding PMVP

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Viking Global Investors's PMVP Position: Q2 2022 in Review

Viking Global Investors sold out of PMV Pharmaceuticals (PMVP) in Q2 2022, closing a stake of 1,076,000 shares — an estimated $22.4M sold.

Viking Global Investors first reported a position in PMVP in Q3 2020 and held it in 7 quarters. The position peaked at $145M in Q4 2020. 105 funds tracked by Wall St. Rank hold PMVP as of Q2 2022.

  • Viking Global Investors reported no remaining PMV Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Viking Global Investors sold 1,076,000 PMV Pharmaceuticals shares in Q2 2022, an estimated $22.4M.
  • Viking Global Investors first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 7 quarters.
  • Viking Global Investors's PMV Pharmaceuticals position peaked at $145M in Q4 2020.
  • 105 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q2 2022.

Based on Viking Global Investors's 13F filing for Q2 2022, filed 15 Aug 2022.